Interactions Between Immune Cells of Intestinal Mucosa or Peripheral Blood With the Extracellular Matrix in Inflammatory Bowel Disease (IBD)

Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants.

NCT07172945 ·Status: NOT_YET_RECRUITING ·Phase: NA

A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease

NCT03251118 ·Status: ACTIVE_NOT_RECRUITING

Construction and Validation of a Predictive Model for the Efficacy of Different Biologics in Inflammatory Bowel Disease

NCT07181525 ·Status: RECRUITING

The Role of Peripheral and Tissue Chitinase 3-like 1 Protein Levels as a Bio-marker in IBD

NCT03154905 ·Status: COMPLETED

Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease

NCT05014555 ·Status: UNKNOWN

Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis

NCT01671956 ·Status: TERMINATED ·Phase: PHASE2

Predictors of Mucosal Healing in Inflammatory Bowel Disease (IBD) Patients Treated With Anti-TNF

NCT01605175 ·Status: COMPLETED

Advanced Therapy Registry of IBD Patients

NCT04998084 ·Status: UNKNOWN

Manipulating the Microbiome in IBD by Antibiotics and FMT

NCT02033408 ·Status: COMPLETED ·Phase: NA

Cohort of Inflammatory Bowel Disease Patient in Yeouido St. Mary's Hospital

NCT05183256 ·Status: COMPLETED

Significance of MAIT Cells in Inflammatory Bowel Disease

NCT05598346 ·Status: UNKNOWN

Identifying Saliva Markers in Inflammatory Bowel Disease

NCT01590043 ·Status: UNKNOWN

A Study to Evaluate the Safety of PRV-300 in Adult Subjects With Moderately to Severely Active Ulcerative Colitis

NCT03849599 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Blood Platelet Indices,Platelet Aggregation in the Activity of IBD Patients on Biological Treatment

NCT05406934 ·Status: UNKNOWN

Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease

NCT03801928 ·Status: COMPLETED

The Effects of Physical Activity on Patients With Inflammatory Bowel Disease

NCT02222584 ·Status: COMPLETED

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

NCT06619990 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Biomarker-based Multidisciplinary Team (Bio-MDT) Approach to Personalized Microbial-targeted Treatment of Pouchitis and Crohn's Disease

NCT04082559 ·Status: UNKNOWN ·Phase: NA

A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease

NCT02904590 ·Status: COMPLETED

Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients

NCT01341808 ·Status: COMPLETED ·Phase: PHASE4

The Effect of Intestinal Microbiota Transplantation for Inflammatory Bowel Diseases

NCT03426683 ·Status: COMPLETED ·Phase: NA

Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis

NCT03765450 ·Status: ACTIVE_NOT_RECRUITING

The Inflammatory Bowel Disease - Anti-Inflammatory Diet (IBD-AID)

NCT04757181 ·Status: COMPLETED ·Phase: NA

Fecal Microbiota Transplantation in Ulcerative Colitis

NCT03273465 ·Status: UNKNOWN ·Phase: PHASE2

Impact of Anti-Tumor Necrosis Factor (TNF) Antibodies on the T-lymphocyte and Macrophage Cooperation in Crohn Disease

NCT00561548 ·Status: TERMINATED ·Phase: NA